- Home
- CAG vs QGEN Comparison
CAG vs QGEN Comparison
Compare CAG & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAG
- QGEN
- Stock Information
- Founded
- CAG 1919
- QGEN 1986
- Country
- CAG United States
- QGEN Netherlands
- Employees
- CAG N/A
- QGEN N/A
- Industry
- CAG Packaged Foods
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAG Consumer Staples
- QGEN Health Care
- Exchange
- CAG Nasdaq
- QGEN Nasdaq
- Market Cap
- CAG 10.3B
- QGEN 9.1B
- IPO Year
- CAG N/A
- QGEN 1996
- Fundamental
- Price
- CAG $19.41
- QGEN $48.08
- Analyst Decision
- CAG Hold
- QGEN Buy
- Analyst Count
- CAG 10
- QGEN 8
- Target Price
- CAG $21.90
- QGEN $50.68
- AVG Volume (30 Days)
- CAG 10.7M
- QGEN 1.3M
- Earning Date
- CAG 07-10-2025
- QGEN 08-05-2025
- Dividend Yield
- CAG 7.22%
- QGEN 3.14%
- EPS Growth
- CAG 233.33
- QGEN N/A
- EPS
- CAG 2.40
- QGEN 0.42
- Revenue
- CAG $11,612,800,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- CAG $0.45
- QGEN $6.36
- Revenue Next Year
- CAG N/A
- QGEN $6.18
- P/E Ratio
- CAG $8.08
- QGEN $115.46
- Revenue Growth
- CAG N/A
- QGEN 3.31
- 52 Week Low
- CAG $18.82
- QGEN $37.63
- 52 Week High
- CAG $33.24
- QGEN $48.90
- Technical
- Relative Strength Index (RSI)
- CAG 24.23
- QGEN 59.71
- Support Level
- CAG $18.82
- QGEN $47.25
- Resistance Level
- CAG $21.37
- QGEN $48.90
- Average True Range (ATR)
- CAG 0.59
- QGEN 0.81
- MACD
- CAG -0.09
- QGEN -0.12
- Stochastic Oscillator
- CAG 16.38
- QGEN 68.98
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (over 90% of fiscal 2024 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2024 revenue coming from international markets and 10% from foodservice.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).